Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channels
Arianne Papa, … , Manu Ben-Johny, Steven O. Marx
Arianne Papa, … , Manu Ben-Johny, Steven O. Marx
Published January 16, 2024
Citation Information: J Clin Invest. 2024;134(5):e176943. https://doi.org/10.1172/JCI176943.
View: Text | PDF
Research Article Cardiology

A membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channels

  • Text
  • PDF
Abstract

The ability to fight or flee from a threat relies on an acute adrenergic surge that augments cardiac output, which is dependent on increased cardiac contractility and heart rate. This cardiac response depends on β-adrenergic–initiated reversal of the small RGK G protein Rad–mediated inhibition of voltage-gated calcium channels (CaV) acting through the Cavβ subunit. Here, we investigate how Rad couples phosphorylation to augmented Ca2+ influx and increased cardiac contraction. We show that reversal required phosphorylation of Ser272 and Ser300 within Rad’s polybasic, hydrophobic C-terminal domain (CTD). Phosphorylation of Ser25 and Ser38 in Rad’s N-terminal domain (NTD) alone was ineffective. Phosphorylation of Ser272 and Ser300 or the addition of 4 Asp residues to the CTD reduced Rad’s association with the negatively charged, cytoplasmic plasmalemmal surface and with CaVβ, even in the absence of CaVα, measured here by FRET. Addition of a posttranslationally prenylated CAAX motif to Rad’s C-terminus, which constitutively tethers Rad to the membrane, prevented the physiological and biochemical effects of both phosphorylation and Asp substitution. Thus, dissociation of Rad from the sarcolemma, and consequently from CaVβ, is sufficient for sympathetic upregulation of Ca2+ currents.

Authors

Arianne Papa, Pedro J. del Rivero Morfin, Bi-Xing Chen, Lin Yang, Alexander N. Katchman, Sergey I. Zakharov, Guoxia Liu, Michael S. Bohnen, Vivian Zheng, Moshe Katz, Suraj Subramaniam, Joel A. Hirsch, Sharon Weiss, Nathan Dascal, Arthur Karlin, Geoffrey S. Pitt, Henry M. Colecraft, Manu Ben-Johny, Steven O. Marx

×

Figure 1

Extent of adrenergic regulation of Ca2+ channels is independent of a specific of CaVβ subunit isoform.

Options: View larger image (or click on image) Download as PowerPoint
Extent of adrenergic regulation of Ca2+ channels is independent of a spe...
(A) Schematic depicting CaVβ domains. NT, N-terminus; CT, C-terminus; Src homology 3 (SH3) domain, a conserved guanylate kinase (GK) domain, and a variable and flexible HOOK region that connects them. In β2-null mice, a frame-shift insertion causes an early termination at the end of the SH3 domain. (B) Anti-β2 and anti-FLAG immunoblots. (C) Anti-FLAG and anti-β2 immunofluorescence of nontransgenic WT and transgenic (TG) FLAG-β–expressing cardiomyocytes. Nuclear staining with DAPI. Scale bars: 50 μm. Representative of 3 similar experiments. Insets, ×4 enlargement to show striated pattern of expression. (D–G) Exemplar current-voltage relationships of Ca2+ channels in the absence (black trace) and presence of forskolin (blue trace). Insets: Exemplar whole-cell CaV1.2 currents. Pulses from –60 mV to +10 mV before (black traces) and 3 minutes after (blue traces) forskolin. Horizontal scale bars = 50 ms, vertical scale bars = 10 pA/pF. (H) Fold change at –20 mV in peak current caused by forskolin (FSK). Mean ± SEM. P = not significant (NS) by 1-way ANOVA; n = 13, 16, 14, and 17 cardiomyocytes from 7, 3, 4, and 6 mice. TG, transgenic. (I) Boltzmann function parameter, V50, before and after FSK. Mean ± SEM. Statistical analysis among non-TG, β2, β3, and β4: P < 0.0001 by 1-way ANOVA; ***P < 0.001 by Šidák’s multiple-comparison test. Statistical analysis of no FSK versus FSK: ****P < 0.0001 by paired, 2-tailed t test. (J) Field stimulation–induced change in sarcomere contraction. ****P < 0.0001 by paired, 2-tailed t test. (K) Forskolin-induced fold change in sarcomere length. Mean ± SEM. n = 20, 20, 28, and 19 from 3, 3, 3, and 3 mice, from left to right. P = not significant by 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts